Drugs Not Selected for Medicare Price Negotiation Nearly Doubled - Report

Seeking AlphaJan 9 11:35 ET

FDA Accepts Astellas Pharma's Revised SNDA For IZERVAY In Geographic Atrophy Treatment

RTTNewsJan 8 19:53 ET

Astellas Pharma's Resubmission for IZERVAY Accepted by FDA

TipRanksJan 8 18:52 ET

Human Embryonic Stem Cells Industry to Generate Revenues of $6.76 Billion by 2035, up From $2.26 Billion 2024 - Thermo Fisher Scientific, STEMCELL Technologies, and Astellas Pharma Dominate the Landscape

Yahoo FinanceJan 8 09:42 ET

Solid Biosciences Stock Jumps 11% Post-market on FDA Update

Seeking AlphaJan 7 17:23 ET

Reported Earlier, China's NMPA Approves Astellas' VYLOY (Zolbetuximab) For Advanced Gastric Cancer Treatment

BenzingaJan 6 01:55 ET